Koers VIA Pharmaceuticals, Inc. Other OTC
Aandelen
VIAP
US92554T1034
Biotechnologie & Medisch Onderzoek
Omzet 2009 | - | Omzet 2010 | - | Marktkapitalisatie | 822K 757K |
---|---|---|---|---|---|
Nettowinst (verlies) 2009 | -21 mln. -19,32 mln. | Nettowinst (verlies) 2010 | -9 mln. -8,28 mln. | EV/omzet 2009 | - |
Nettoschuld 2009 | 7,81 mln. 7,18 mln. | Nettoschuld 2010 | 13,92 mln. 12,81 mln. | EV/omzet 2010 | - |
K/w-verhouding 2009 |
-0,19
x | K/w-verhouding 2010 |
-0,08
x | Werknemers | - |
Dividendrendement 2009 * |
-
| Dividendrendement 2010 |
-
| Vrij verhandelbaar | 100% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 70 | 01-07-04 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 70 | 01-07-04 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
-0,09% | 42,12 mld. | |
+49,62% | 42,05 mld. | |
-4,96% | 29,18 mld. | |
+11,18% | 26,02 mld. | |
-21,95% | 18,9 mld. | |
+8,61% | 13,21 mld. | |
+24,73% | 12,17 mld. | |
+28,31% | 12,16 mld. | |
-6,26% | 11,42 mld. |